top of page
gradientForSurfBreak.png

Item List

Buesinesswire
COMPaSS™ Personalized Spine Surgery Study Begins Enrollment

Carlsmed® announced today that the first patients have been enrolled in the COMPaSS™ study. COMPaSS, Clinical Outcome Measures in Personalized aprevo® Spine Surgery, is a multi-center post market prospective observational registry. The study will collect data on patients with degenerative spinal conditions and are treated surgically with Carlsmed aprevo devices and will track outcomes for a period of two years.

Recent Posts

Portfolio Company

Carlsmed.png

Robotic Pet Company Tombot Secures $6.1M Series A Funding to Support Groundbreak ...

Businesswire

Portfolio Company

Carlsmed.png

Warrington Hospital to Use AI to Speed Up Diagnosis of Skin Cancer
...

Yahoo News

Portfolio Company

Carlsmed.png

Matterworks: Series A Funding Raised For Advancing Large Spectral Models
...

Pulse 2.0

surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page